Consistent with this tumor-promoting phenotype, flow cytometry analysis revealed that B16-F10-hcystatin C overexpression significantly increased the proportion of LILRB2+ myeloid cells among total myeloid cells in LILRB2KI mice (Fig. 5c), indicating a more immunosuppressive TME. The gene discussed is LILRB2; the disease is neoplasm.